Study of preoperative focused microwave phased array thermotherapy in combination with neoadjuvant anthracycline-based chemotherapy for large breast carcinomas
نویسندگان
چکیده
Hernan I. Vargas*, William C. Dooley, Alan J. Fenn, Mary Beth Tomaselli, Jay K. Harness Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, California The University of Oklahoma, Health Sciences Center, Oklahoma City, Oklahoma Massachusetts Institute of Technology, Lexington, Massachusetts Comprehensive Breast Center, Coral Springs, Florida St. Joseph’s Hospital, Orange, California __________________________________________________________________________________
منابع مشابه
Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 And 2014
Background and objective:Breast cancer is the most common malignancy among women. The Neoadjuvant chemotherapy is the treatment of choice for non-operable tumors. The Ki67 is a proliferation marker that can be used to predict the therapeutic response to chemotherapy and the patients' prognosis. Methods: This retrospective study was carri...
متن کاملPrimary systemic therapy of breast cancer.
Primary systemic therapy (PST) or neoadjuvant therapy is used in nonmetastatic breast cancer to treat systemic disease earlier, decrease tumor bulk ideally to a complete pathological response (pCR), and reduce the extent of surgery. The multitude of clinical trials using PST in breast cancer patients has not proven the fundamental hypotheses of improved overall survival and disease-free surviva...
متن کاملPreoperative Chemotherapy for Breast Cancer: Theoretical Considerations, Summary of Research Findings, and Clinical Recommendations
This review summarises the literature on non-randomised and randomised clinical trials on preoperative chemotherapy in breast cancer. The effectiveness and survival benefits of adjuvant anthracycline-based chemotherapy and, more recently, taxane-containing regimens have led to more frequent use of preoperative chemotherapy as neoadjuvant treatment in operable breast cancers. However, survival b...
متن کاملXeNA: Capecitabine Plus Docetaxel, With or Without Trastuzumab, as Preoperative Therapy for Early Breast Cancer
Combinations of capecitabine and a taxane are highly active in metastatic breast cancer, and synergy between capecitabine and docetaxel has also been demonstrated. Such combinations potentially would provide a promising non-anthracycline-based alternative for patients with early breast cancer. Non-anthracycline preoperative regimens are a particularly interesting proposition in human epidermal ...
متن کاملNeoadjuvant Chemotherapy with Breast Conservation for Locally Advanced Ductal and Lobular Invasive Carcinomas Combining Multimodality Strategies
Background : Breast-Conserving surgery (BCS) has generally been limited to T1 and T2 lesions because it has been thought impossible to achieve good local control with satisfactory cosmesis in patient with more advanced disease. However, many patients with T3 and T4 lesions will exhibit dramatic tumor down staging with neoadjuvant Chemotherapy. Several studies reports low rates of breast conserv...
متن کامل